---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-215838"
form_type: "8-K"
ticker: "AGEN"
cik: "0001098972"
company_name: "AGENUS INC"
filed_at: "2026-05-11T12:52:03+00:00"
generated_at: "2026-05-11T18:27:50.038658+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Agenus Q1 net income $39.2M, revenue $33.7M; SEC closes investigation with no action

## Summary
- Net income of $39.2M vs loss of $26.4M in Q1 2025; total revenue $33.7M (+40% YoY).
- Cash rose to $35.0M at March 31, 2026 from $3.0M at Dec 31, 2025, boosted by Zydus deal proceeds.
- Zydus collaboration closed Jan 2026 providing $91M upfront; Phase 3 BATTMAN trial began enrolling in April.
- SEC concluded its investigation with no enforcement action (May 2026); related class action dismissed in March.

## SEC filing metadata
- accession: 0001193125-26-215838
- form_type: 8-K
- ticker: AGEN
- cik: 0001098972
- company_name: AGENUS INC
- filed_at: 2026-05-11T12:52:03+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1098972/000119312526215838/0001193125-26-215838-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1098972/000119312526215838/agen-20260511.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-215838
- JSON: https://secwatch.observer/filing/0001193125-26-215838.json
- Plain text: https://secwatch.observer/filing/0001193125-26-215838.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.